Impact BioMedical, Net Worth
Impact BioMedical, Net Worth Breakdown | IBO |
Impact BioMedical, Net Worth Analysis
Impact BioMedical,'s net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Impact BioMedical,'s financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Impact BioMedical,'s overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Impact BioMedical,'s net worth analysis. One common approach is to calculate Impact BioMedical,'s market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Impact BioMedical,'s stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Impact BioMedical,'s net worth. This approach calculates the present value of Impact BioMedical,'s future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Impact BioMedical,'s cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Impact BioMedical,'s net worth. This involves comparing Impact BioMedical,'s financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Impact BioMedical,'s net worth relative to its peers.
Enterprise Value |
|
To determine if Impact BioMedical, is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Impact BioMedical,'s net worth research are outlined below:
| Impact BioMedical, is way too risky over 90 days horizon | |
| Impact BioMedical, may become a speculative penny stock | |
| Impact BioMedical, appears to be risky and price may revert if volatility continues | |
| Impact BioMedical, has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (4.34 M) with profit before taxes, overhead, and interest of 0. | |
| Impact BioMedical, generates negative cash flow from operations | |
| Impact BioMedical, has a frail financial position based on the latest SEC disclosures | |
| About 55.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Discretionary transaction by Dss, Inc. of tradable shares of Impact BioMedical, subject to Rule 16b-3 |
Impact BioMedical, Quarterly Good Will |
|
Follow Impact BioMedical,'s market capitalization trends
The company currently falls under 'Micro-Cap' category with a total capitalization of 22.2 M.Market Cap |
|
Project Impact BioMedical,'s profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.91) | (2.01) | |
| Return On Capital Employed | 0.10 | 0.11 | |
| Return On Assets | (1.91) | (2.01) | |
| Return On Equity | (3.06) | (3.21) |
When accessing Impact BioMedical,'s net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Impact BioMedical,'s profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Impact BioMedical,'s profitability and make more informed investment decisions.
Evaluate Impact BioMedical,'s management efficiency
Impact BioMedical, has Return on Asset of (0.0499) % which means that on every $100 spent on assets, it lost $0.0499. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0345 %, implying that it generated $0.0345 on every 100 dollars invested. Impact BioMedical,'s management efficiency ratios could be used to measure how well Impact BioMedical, manages its routine affairs as well as how well it operates its assets and liabilities. As of the 8th of January 2025, Return On Capital Employed is likely to grow to 0.11, while Return On Tangible Assets are likely to drop (2.01). As of the 8th of January 2025, Other Current Assets is likely to grow to about 125.6 K, while Total Assets are likely to drop about 39.1 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.02 | 0.02 | |
| Tangible Book Value Per Share | 0.02 | 0.02 | |
| Enterprise Value Over EBITDA | (1.87) | (1.78) | |
| Price Book Value Ratio | 1.89 | 1.80 | |
| Enterprise Value Multiple | (1.87) | (1.78) | |
| Price Fair Value | 1.89 | 1.80 | |
| Enterprise Value | 6.8 M | 6.2 M |
Impact BioMedical,'s management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Impact BioMedical, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Impact BioMedical,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Impact BioMedical, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Dss, Inc. 2 days ago Discretionary transaction by Dss, Inc. of tradable shares of Impact BioMedical, subject to Rule 16b-3 | ||
Heuszel Frank D over a month ago Acquisition by Heuszel Frank D of 500 shares of Impact BioMedical, at 2.2578 subject to Rule 16b-3 | ||
Heuszel Frank D over a month ago Acquisition by Heuszel Frank D of 500 shares of Impact BioMedical, at 2.61 subject to Rule 16b-3 | ||
Heuszel Frank D over a month ago Acquisition by Heuszel Frank D of 550 shares of Impact BioMedical, at 2.625 subject to Rule 16b-3 | ||
Dss, Inc. over a month ago Disposition of 5000 shares by Dss, Inc. of Impact BioMedical, at 3.017 subject to Rule 16b-3 | ||
Dss, Inc. over a month ago Disposition of 200 shares by Dss, Inc. of Impact BioMedical, at 2.8 subject to Rule 16b-3 | ||
Dss, Inc. over a month ago Disposition of 500 shares by Dss, Inc. of Impact BioMedical, at 2.757 subject to Rule 16b-3 | ||
Dss, Inc. over three months ago Acquisition by Dss, Inc. of 1000 shares of Impact BioMedical, at 2.33 subject to Rule 16b-3 |
Impact BioMedical, Earnings per Share Projection vs Actual
When determining whether Impact BioMedical, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Impact BioMedical,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Impact Biomedical, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Impact Biomedical, Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impact BioMedical,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical, guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Impact BioMedical,. If investors know Impact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Impact BioMedical, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Impact BioMedical, is measured differently than its book value, which is the value of Impact that is recorded on the company's balance sheet. Investors also form their own opinion of Impact BioMedical,'s value that differs from its market value or its book value, called intrinsic value, which is Impact BioMedical,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Impact BioMedical,'s market value can be influenced by many factors that don't directly affect Impact BioMedical,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Impact BioMedical,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.